AlphaCrest Capital Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$658,000
+224.1%
8,883
+176.8%
0.04%
+263.6%
Q1 2022$203,000
-68.5%
3,209
-73.6%
0.01%
-54.2%
Q4 2021$645,000
+184.1%
12,166
+256.8%
0.02%
+140.0%
Q2 2021$227,000
-63.0%
3,410
-38.4%
0.01%
-70.6%
Q1 2021$614,000
+24.3%
5,533
+33.1%
0.03%
-17.1%
Q4 2020$494,000
+65.2%
4,156
+24.5%
0.04%
-18.0%
Q2 2020$299,000
+9.5%
3,339
+22.1%
0.05%
+51.5%
Q1 2020$273,000
-33.7%
2,735
-23.8%
0.03%
-2.9%
Q4 2019$412,000
+5.1%
3,589
+15.6%
0.03%
+41.7%
Q3 2019$392,000
-13.5%
3,105
-40.1%
0.02%
-65.2%
Q1 2019$453,0005,1820.07%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders